{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:57:35Z","timestamp":1789952255415,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01653","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T05:17:13Z","timestamp":1563254233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Manuela","family":"Colucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Carsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Serafinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Massella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lo Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Capponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cotugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Onetti Muda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2215\/CJN.08500815","article-title":"Anti-CD20 antibodies for idiopathic nephrotic syndrome in children","volume":"11","author":"Ravani","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4049\/jimmunol.180.1.361","article-title":"Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice","volume":"180","author":"Dilillo","year":"2008","journal-title":"J Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/art.22810","article-title":"Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy","volume":"56","author":"Anolik","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.autrev.2017.04.007","article-title":"Rituximab for immunologic renal disease: what the nephrologist needs to know","volume":"16","author":"Kronbichler","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2217\/imt-2017-0178","article-title":"Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution","volume":"10","author":"Sacco","year":"2018","journal-title":"Immunotherapy."},{"key":"B10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00467-012-2361-z","article-title":"Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?","volume":"28","author":"Delbe-Bertin","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00467-018-4063-7","article-title":"Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study","volume":"34","author":"Takahashi","year":"2019","journal-title":"Pediatr Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/bcp.13548","article-title":"Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome","volume":"84","author":"Bonanni","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00467-018-4095-z","article-title":"B cell phenotype in pediatric idiopathic nephrotic syndrome","volume":"34","author":"Colucci","year":"2019","journal-title":"Pediatr Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cyto.b.20536","article-title":"B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood","volume":"78","author":"Piatosa","year":"2010","journal-title":"Cytometry B Clin Cytom."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar3908","article-title":"B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies","volume":"15","author":"Leandro","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e112658","DOI":"10.1371\/journal.pone.0112658","article-title":"Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy","volume":"9","author":"Kamburova","year":"2014","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM197507032930103","article-title":"Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome","volume":"293","author":"Giangiacomo","year":"1975","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","article-title":"Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome","volume":"17","author":"Kemper","year":"2002","journal-title":"Pediatr Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2474-15-178","article-title":"The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease","volume":"15","author":"Marco","year":"2014","journal-title":"BMC Musculoskelet Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/acr.22993","article-title":"Pragmatic treatment of patients with systemic lupus erythematosus with rituximab: long-term effects on serum immunoglobulins","volume":"69","author":"Reddy","year":"2017","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","article-title":"Peripheral development of B cells in mouse and man","volume":"197","author":"Carsetti","year":"2004","journal-title":"Immunol Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/jclinpath-2018-205168","article-title":"Automated enumeration of lymphoid and plasma cells in bone marrow to establish normal reference ranges","volume":"71","author":"Liang","year":"2018","journal-title":"J Clin Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1182\/blood-2016-01-694356","article-title":"Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy","volume":"128","author":"Bhoj","year":"2016","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood-2016-06-717538","article-title":"To B or not to B maintained?","volume":"128","author":"Palm","year":"2016","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00467-013-2538-0","article-title":"Seroprotection for hepatitis B in children with nephrotic syndrome","volume":"28","author":"Mantan","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","article-title":"Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety?","volume":"31","author":"Yildiz","year":"2013","journal-title":"Vaccine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5414\/CN107779","article-title":"Large decrease of anti-tetanus anatoxin and anti-pneumococcal antibodies at one year after renal transplantation","volume":"79","author":"Broeders","year":"2013","journal-title":"Clin Nephrol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/eji.201041187","article-title":"Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example","volume":"41","author":"Rosado","year":"2011","journal-title":"Eur J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.4161\/hv.21827","article-title":"Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions","volume":"8","author":"Cagigi","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","article-title":"Immunology of idiopathic nephrotic syndrome","volume":"33","author":"Colucci","year":"2018","journal-title":"Pediatr Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaut.2017.10.006","article-title":"NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in minimal change nephrotic syndrome","volume":"88","author":"Boumediene","year":"2018","journal-title":"J Autoimmun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T05:17:15Z","timestamp":1563254235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2019.01653"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01653","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"article-number":"1653"}}